Human immunodeficiency virus postexposure prophylaxis in child and adolescent victims of sexual assault

被引:13
作者
Schremmer, RD
Swanson, D
Kraly, K
机构
[1] Childrens Mercy Hosp & Clin, Div Emergency Med Serv, Kansas City, MO 64108 USA
[2] Childrens Mercy Hosp & Clin, Infect Dis Sect, Kansas City, MO USA
[3] Childrens Mercy Hosp & Clin, Sect Gen Pediat, Kansas City, MO USA
关键词
human immunodeficiency virus; postexposure prophylaxis; sexual assault;
D O I
10.1097/01.pec.0000173347.53271.38
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objectives: This study was performed at an urban children's hospital to identify the characteristics of patients given human immunodeficiency virus (HIV) postexposure prophylaxis and describe the adherence and associated side effects of HIV prophylaxis in child and adolescent victims of sexual abuse. Methods: A retrospective review of all children presenting for evaluation of suspected sexual abuse who were provided HIV prophylaxis between February 1999 and March 2001 was performed. Measured variables included risk factors for transmission of HIV, antiretrovirals prescribed and their side effects, initial and follow-up laboratory results, and compliance. Results: The medical records of 34 patients were examined. Assault by a stranger was the most common risk factor prompting prophylaxis. Zidovudine and lamivudine were prescribed for 32 patients (94%). Only 17 patients (50%) kept at least 1 follow-up appointment; 8 patients (24%) finished the entire course of prophylaxis. Side effects were reported in 11 (65%) of 17 patients, but only 1 patient was known to have stopped prophylaxis because of subjective side effects, and 1 patient was removed from prophylaxis due to laboratory abnormality. Conclusions: Adherence to medication regimen and follow-up appointments in victims of suspected sexual abuse who are provided HIV prophylaxis is poor. The medications are associated with several side effects, but rarely do the side effects prohibit their use. Given difficulties with compliance, potential adverse effects of medications, and the high cost of treatment, care should be taken in offering prophylaxis to only those at increased risk for transmission of disease.
引用
收藏
页码:502 / 506
页数:5
相关论文
共 17 条
[1]  
[Anonymous], 1998, MMWR Recomm Rep, V47, P1
[2]   HIV postexposure prophylaxis for children and adolescents [J].
Babl, FE ;
Cooper, ER ;
Damon, B ;
Louie, T ;
Kharasch, S ;
Harris, JA .
AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2000, 18 (03) :282-287
[3]   A case-control study of HIV seroconversion in health care workers after percutaneous exposure [J].
Cardo, DM ;
Culver, DH ;
Ciesielski, CA ;
Srivastava, PU ;
Marcus, R ;
Abiteboul, D ;
Heptonstall, J ;
Ippolito, G ;
Lot, F ;
McKibben, P ;
Bell, DM .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (21) :1485-1490
[4]  
*CDCP, 1995, MMWR-MORBID MORTAL W, V44, P929
[5]   REDUCTION OF MATERNAL-INFANT TRANSMISSION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 WITH ZIDOVUDINE TREATMENT [J].
CONNOR, EM ;
SPERLING, RS ;
GELBER, R ;
KISELEV, P ;
SCOTT, G ;
OSULLIVAN, MJ ;
VANDYKE, R ;
BEY, M ;
SHEARER, W ;
JACOBSON, RL ;
JIMENEZ, E ;
ONEILL, E ;
BAZIN, B ;
DELFRAISSY, JF ;
CULNANE, M ;
COOMBS, R ;
ELKINS, M ;
MOYE, J ;
STRATTON, P ;
BALSLEY, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (18) :1173-1180
[6]  
de la Tribonniere X, 1998, INT J STD AIDS, V9, P591, DOI 10.1258/0956462981921170
[7]   TOLERABILITY, SAFETY, AND ACCEPTABILITY OF ZIDOVUDINE PROPHYLAXIS IN HEALTH-CARE WORKERS [J].
FORSETER, G ;
JOLINE, C ;
WORMSER, GP .
ARCHIVES OF INTERNAL MEDICINE, 1994, 154 (23) :2745-2749
[8]  
Ippolito Giuseppe, 1997, American Journal of Medicine, V102, P58, DOI 10.1016/S0002-9343(97)00064-8
[9]  
Jochimsen Elise M., 1997, American Journal of Medicine, V102, P52, DOI 10.1016/S0002-9343(97)00062-4
[10]   Postexposure treatment of people exposed to the human immunodeficiency virus through sexual contact or injection-drug use [J].
Katz, MH ;
Gerberding, JL .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (15) :1097-1100